packageMavacamten

mavacamten

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mavacamten is a heart medicine used to treat hypertrophic cardiomyopathy. It is authorised in the European Union and is an approved drug, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q105337531 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mavacamten
ATC codes:C01EB24
DrugBank:DB14921
PubChem CID:117761397
Wikidata:Q105337531
formula:C15H19N3O2
molar mass:273.336 g/mol (PubChem CID 117761397)
logP:2.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown